Table 3.
Results of univariable Cox proportional hazards analysis to evaluate factors associated with a shorter time to cardiac death
| Factor | Hazard Ratio | 95% Confidence Intervals | P Value |
|---|---|---|---|
| TAPSE (≥15.1 mm) | Ref. | ||
| TAPSE (<15.1 mm) | 6.1 | 1.8–21.0 | .004 |
| Weight: continuous per +1 kg | 1.1 | 1.0–1.2 | .028 |
| Sex: Male = No | Ref. | ||
| Sex: Male = Yes | 1.8 | 0.7–4.5 | .23 |
| ARVC diagnosis = no | Ref. | ||
| ARVC diagnosis = yes | 7.3 | 2.1–25.5 | .002 |
| LV systolic dysfunction = No | Ref. | ||
| LV systolic dysfunction = Yes | 5.9 | 1.3–26.1 | .019 |
| LA:Ao (<1.76) | Ref. | ||
| LA:Ao (≥1.76) | 2.4 | 0.9–6.8 | .088 |
| Presence of CHF = No | Ref. | ||
| Presence of CHF = Yes | 5.7 | 2.1–16.0 | .001 |
| Presence of VT = No | Ref. | ||
| Presence of VT = Yes | 5.6 | 2.2–14.2 | <.001 |
TAPSE, tricuspid annular plane systolic excursion; VPCs, ventricular premature complexes; LV, left ventricle; LA, left atrium; Ao, aorta; CHF, congestive heart failure; VT, ventricular tachycardia.